Issue link: https://viewer.e-digitaledition.com/i/82081
++++++++++++++++++++ TECHNOLOGY +++ +++ ++++++++++++++++++++ + + Brain-Imaging Technique Makes Cognitive Decline Predictable A BRAIN-IMAGING TOOL USED TO ASSESS CHANGES IN THE BRAIN ASSOCIATED WITH COGNITIVE LOSS COULD NOW PLAY A KEY ROLE IN EVALUATING THE CONDITION'S EARLIER STAGES. R ESEARCHERS AT THE University of California, Los Angeles, recently conducted a study involving the creation of FDDNP, a chemical marker that attaches to plaque and tau protein deposits in the brain associated with the development of Alzheimer's disease (AD). After its introduction into the body, the marker can be viewed using positron emission tomography (PET), allowing scientists to identify locations in the brain where the abnormal deposits are amassing. Study participants — averaging 64 years of age and without dementia — underwent brain scanning, cognitive evaluation and testing using the FDDNP- PET technique. After a follow-up visit at two years, results revealed that the biomarkers bound to key areas of the brain correlating with a decrease in cognitive skills such as attention span and language. Gary Small, M.D., professor of psy- chiatry and biobehavioral sciences at the David Geffen School of Medicine at UCLA, Director of the UCLA Longevity Center and author of the study, says the 36 | Lower Hudson/Bronx MD NEWS n MDNEWS.COM FDDNP-PET technique is cur- rently the only scan marker that can visualize how tau tangles set into position, which he describes is a dependable indicator of AD. "Tau tangles correlate better with disease progression than do amyloid plaques," Dr. Small says. "We can see tau tangle deposition that is more predictive of future cognitive decline and dementia, which may suggest that there could be more candidates for anti-tau and anti-AD treatments." Treatment Possibilities Currently, 5.4 million Americans are living with AD, according to the Alzheimer's Association, and the disease affects nearly half of the population older than 85. Despite ranking in the top 10 causes of death in the United States, AD currently has neither a cure nor means to prevent disease progression. Researchers hope the FDDNP-PET technique could yield a method to prevent tangles earlier and assist in tracking the effectiveness of current anti-AD treatments and drugs, including curcumin — a compound found in the Indian spice turmeric that boasts anti-tau and anti-infl ammatory properties and could play a role in the prevention of brain tangles associated with AD. Dr. Small adds that researchers are also looking for ways to evaluate future treatment options and whether the brain-scan patterns can predict who will respond to treatment. "My hope is that we can use this kind of tool to test new treatments before people have dementia," Dr. Small says. "Our research group focuses on trying to protect a healthy brain rather than trying to repair the brain once it's damaged. These tools can help us accelerate that." n

